Nitric oxide mediates low magnesium inhibition of osteoblast-like cell proliferation

Journal of Nutritional Biochemistry

Volumn 23, Issue 10, 2012, Pages 1224-1229

  Leidi, Marzia ^a   Dellera, Federica ^a   Mariotti, Massimo ^a   Banfi, Giuseppe ^b   Crapanzano, Calogero ^c   Albisetti, Walter ^b   Maier, Jeanette A M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

Author keywords

INOS; Magnesium; Nitric oxide; Osteoblast; Osteoporosis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; APOCYNIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LEVO N6 (IMINOETHYL) LYSINE HYDROCHLORIDE; MAGNESIUM; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE; OXYGENASE INHIBITOR; SMALL INTERFERING RNA; TROLOX C; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; HOMEOSTASIS; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; UPREGULATION;

CELL LINE; CELL PROLIFERATION; HUMANS; MAGNESIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOBLASTS; OSTEOPOROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84866341134     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.06.016     Document Type: Article

References (45)

1. Guerrera M.P., Volpe S.L., Mao J.J. Therapeutic uses of magnesium. Am Fam Physician 2009, 80(2):157-162.
2. Standing Committee on the scientific evaluation of dietary reference intake, food and nutrition board, Institute of Medicine in dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride 1997, 190-249. Natl Acad Press, Washington DC.
3. Ford E.S., Mokdad A.H. Dietary magnesium intake in a national sample of US adults. J Nutr 2003, 133(9):2879-2882.
4. Barbagallo M., Belvedere M., Dominguez L.J. Magnesium homeostasis and aging. Magnes Res 2009, 22(4):235-246.
5. Rude R.K., Gruber H.E. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem 2004, 15(12):710-716.
6. Rude R.K., Singer F.R., Gruber H.E. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009, 28(2):131-141.
7. Abed E., Moreau R. Importance of melastatin-like transient receptor potential 7 and cations (magnesium, calcium) in human osteoblast-like cell proliferation. Cell Prolif 2007, 40(6):849-865.
8. Bigi A., Foresti E., Gregorini R., Ripamonti A., Roveri N., et al. The role of magnesium on the structure of biological apatites. Calcif Tissue Int 1992, 50(5):439-449.
9. Rude R.K., Oldhan S.B., Singer F.R. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human Mg deficiency. Clin Endocrinol 1976, 5(3):209-224.
10. Risco F., Traba M.L. Influence of magnesium on the in vitro synthesis of 24,25 dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3. Magnes Res 1992, 5(1):5-14.
11. Sahota O., Mundey M.K., San P., Godber I.M., Hosking D.J. Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 2006, 17(7):1013-1021.
12. Saggese G., Federico G., Bertelloni S., Baroncelli G.I., Calisti L. Hypomagnesemia and the parathyroid hormone-vitamin D endocrine system in children with insulin-dependent diabetes mellitus: effects of Mg administration. J Pediatr 1991, 118(2):220-225.
13. Creedon A., Flynn A., Cashman K. The effect of moderately and severely restricted dietary magnesium intakes on bone composition and bone metabolism in the rat. Br J Nutr 1999, 82(1):63-71.
14. Rude R.K., Kirchen M.E., Gruber H.E., Meyer M.H., Luck J.S., et al. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption. Magnes Res 1999, 12(4):257-267.
15. Rude R.K., Gruber H.E., Wie L.Y., Frausto A., Mills B.G. Magnesium deficiency: effect on bone and mineral metabolism in the mouse. Calcif Tissue Int 2003, 72:32-41.
16. Mackie E.J. Osteoblasts: novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol 2003, 35(9):1301-1305.
17. Raisz L.G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005, 115(12):3318-3325.
18. Pautke C., Schieker M., Tischer T., Kolk A., Neth P., et al. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res 2004, 24(6):3743-3748.
19. Ferrè S., Baldoli E., Leidi M., Maier J.A. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. Biochim Biophys Acta 2010, 1802(11):952-958.
20. Leidi M., Mariotti M., Maier J.A. EDF-1 contributes to the regulation of nitric oxide release in VEGF-treated human endothelial cells. Eur J Cell Biol 2010, 89(9):654-660.
21. Banai S., Haggroth L., Epstein S.E., Casscells W. Influence of extracellular magnesium on capillary endothelial cell proliferation and migration. Circ Res 1990, 67(3):645-650.
22. Maier J.A., Bernardini D., Rayssiguier Y., Mazur A. High concentrations of magnesium modulate vascular endothelial behaviour in vitro. Biochim Biophys Acta 2004, 1689:6-12.
23. Wolf F.I., Trapani V. Cell pathophysiology of magnesium. Clin Sci 2008, 114:27-35.
24. Hans C.P., Chaudhary D.P., Bansal D.D. Effect of magnesium supplementation on oxidative stress in alloxanic diabetic rats. Magnes Res 2003, 16(1):13-19.
25. Mazur A., Maier J.A., Rock E., Gueux E., Nowacki W., et al. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007, 458(1):48-56.
26. Wimalawansa S.J. Nitric oxide and bone. Ann N Y Acad Sci 2010, 1192:391-403.
27. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597-601.
28. Kleinert H., Pautz A., Linker K., Schwarz P.M. Regulation of the expression of the inducible nitric oxide synthase. Eur J Pharmacol 2004, 500(1-3):255-266.
29. Chan G.K., Duque G. Age-related bone loss: old bone, new facts. Gerontology 2002, 48(2):62-71.
30. Rude R.K., Singer F.R., Gruber H.E. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009, 28:131-141.
31. Rubin H. The membrane, magnesium, mitosis (MMM) model of cell proliferation control. Magnes Res 2005, 18(4):268-274.
32. Maier J.A., Malpuech-Brugère C., Zimowska W., Rayssiguier Y., Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta-Mol Bas Dis 2004, 1689(1):13-21.
33. Altura B.M., Gebrewold A., Zhang A., Altura B.T. Low extracellular magnesium ions induce lipid peroxidation and activation of nuclear factor-kappa B in canine cerebral vascular smooth muscle: possible relation to traumatic brain injury and strokes. Neurosci Lett 2003, 341(3):189-192.
34. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000, 21(2):115-137.
35. Wei S., Kitaura H., Zhou P., Ross F.P., Teitelbaum S.L. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 2005, 115(2):282-290.
36. Pacifici R., Rifas L., McCracken R., Vered I., McMurtry C., et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A 1989, 86(7):2398-2402.
37. Ferrè S., Mazur A., Maier J.A. Low-magnesium induces senescent features in cultured human endothelial cells. Magnes Res 2007, 20(1):66-71.
38. Saura M., Tarin C., Zaragoza C. Recent insights into the implication of nitric oxide in osteoblast differentiation and proliferation during bone development. Sci World J 2010, 10:624-632.
39. Van Bezooijen R.L., Van der Bent C., Papapoulos S.E., Löwik C.W. Oestrogenic compounds modulate cytokine-induced nitric oxide production in mouse osteoblast-like cells. J Pharm Pharmacol 1999, 51(12):1409-1414.
40. Armour K.J., Armour K.E., van't Hof R.J., Reid D.M., Wei X.Q., et al. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 2001, 44(12):2790-2796.
41. Wu F., Tyml K., Wilson J.X. iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells. J Cell Physiol 2008, 217(1):207-214.
42. Yang P., Cao Y., Li H. Hyperglycemia induces inducible nitric oxide synthase gene expression and consequent nitrosative stress via c-Jun N-terminal kinase activation. Am J Obstet Gynecol 2010, 203(2):185.e5-185.e11.
43. Weston C.R., Davis R.J. The JNK signal transduction pathway. Curr Opin Cell Biol 2007, 19(2):142-149.
44. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 2010, 1802(4):396-405.
45. Au-Yeung K.K., Karmin O., Choy P.C., Zhu D.Y., Siow Y.L. Magnesium tanshinoate B protects endothelial cells against oxidized lipoprotein-induced apoptosis. Can J Physiol Pharmacol 2007, 85(11):1053-1062.